Chapter 34: Schizophrenia Medication Therapy Management Data Set

Chapter 34. Schizophrenia Medication Therapy Management Data Set

Which of the following symptoms is included in the diagnostic criteria for schizophrenia?

a. Disorganized speech

b. Anxious mood

c. Depressed mood

d. Illusions

Which of the following is the most appropriate action for the MTM provider when assessing a patient with schizophrenia?

a. Anticipate cataracts as a common medical complication

b. Measure cognitive deficits using a brief clinical rating scale

c. Monitor for tardive dyskinesia only during first-generation antipsychotic treatment

d. Interpret flat affect, poor speech productivity, and low energy as depression, not negative symptoms

When measuring symptom severity of schizophrenia, which of the following best describes the minimally accepted reduction in total scores that qualifies for a response from antipsychotic treatment?

a. Remission

b. 60%

c. 40%

d. 20%

Using living room language, an MTM provider might describe one of the negative symptoms of schizophrenia as:

a. Hearing voices

b. Inner restlessness

c. Constant lack of motivation

d. Always being suspicious of others

A patient with schizophrenia reports that her symptoms have been bothersome for 2 days in a row. Which one of the following should be a part of the medication action plan?

a. Tell the patient to call the psychiatrist and get changed to a new antipsychotic

b. Instruct the patient to double the dose of antipsychotic for a few days until the symptoms go away

c. Instruct the patient to disregard the symptoms

d. Instruct the patient to use coping skills when symptoms occur

All of the following scenarios should result in the MTM provider referring the patient with schizophrenia back to the patient's psychiatrist EXCEPT:

a. When the patient continues to have residual symptoms of schizophrenia over time

b. When the patient's serum triglycerides continuously increase over time